🔎 Trials Near Me

Home › Colorectal Cancer › NCT05663203

A Web-Based Dyadic Intervention for Colorectal Cancer

RecruitingHealthy volunteers welcome

A Web-Based Dyadic Intervention to Manage Psychoneurological Symptoms for Patients With Colorectal Cancer and Their Caregivers

Who can join

Ages 18 and older · All sexes · Healthy volunteers welcome

Full eligibility criteria
INCLUSION CRITERIA

Patients:

* Age \>= 18 years
* Diagnosed with colorectal cancer
* Life expectancy \> 12 months
* Receiving active chemotherapy
* Self-reported at least two psychoneurological symptoms (based on the symptom measures' cutoff scores)
* Identified primary caregiver (i.e., family members or significant others identified by the patients as their primary source of emotional and physical support)
* Access to the Internet
* Fluent in English

Caregivers:

* Age \>= 18 years
* Primary caregiver
* Access to the Internet
* Fluent in English

EXCLUSION CRITERIA

Patients:

• Karnofsky Performance Scale \< 50

Caregivers:

• Have severe diseases (e.g., cancer, heart disease)

About the study

This clinical trial studies how well a web-based dyadic intervention works to manage psychoneurological symptoms for patients with colorectal cancer and their caregivers. Patients with colorectal cancer receiving chemotherapy experience severe and distressing psychoneurological symptoms that include fatigue, depression, sleep disturbance, pain, and cognitive dysfunction. When these co-occurring symptoms are undertreated, they negatively affect functional status, survival rates, and quality of life of patients as well as decrease health outcomes of their family caregiver. A critical need exists to develop an effective and novel intervention that focuses on patients with colorectal cancer receiving chemotherapy and their caregivers. A web-based dyadic intervention holds great promise to reduce psychoneurological symptoms burden and improve quality of life for patients with colorectal cancer receiving chemotherapy and advance intervention development and implementation in cancer supportive care and health equity.

What is being tested

Sponsor: Emory University · Participants: 56 · Started: May 1, 2023

Contact the study team

Official record on ClinicalTrials.gov — NCT05663203

Locations in the U.S.

GeorgiaEmory University/Winship Cancer Institute, Atlanta

Conditions

From ClinicalTrials.gov, data retrieved Oct 2, 2026. Each study sets its own eligibility; the study team decides who can join.